{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:01:56Z","timestamp":1791918116961,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI075045"],"award-info":[{"award-number":["R01AI075045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI089674"],"award-info":[{"award-number":["U19AI089674"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI139520"],"award-info":[{"award-number":["R01AI139520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Uganda, artemether-lumefantrine is recommended for malaria treatment and sulfadoxine-pyrimethamine for chemoprevention during pregnancy, but drug resistance may limit efficacies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genetic polymorphisms associated with sensitivities to key drugs were characterized in samples collected from 16 sites across Uganda in 2018 and 2019 by ligase detection reaction fluorescent microsphere, molecular inversion probe, dideoxy sequencing, and quantitative polymerase chain reaction assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Considering transporter polymorphisms associated with resistance to aminoquinolines, the prevalence of Plasmodium falciparum chloroquine resistance transporter (PfCRT) 76T decreased, but varied markedly between sites (0\u201346% in 2018; 0\u201323% in 2019); additional PfCRT polymorphisms and plasmepsin-2\/3 amplifications associated elsewhere with resistance to piperaquine were not seen. For P. falciparum multidrug resistance protein 1, in 2019 the 86Y mutation was absent at all sites, the 1246Y mutation had prevalence \u226420% at 14 of 16 sites, and gene amplification was not seen. Considering mutations associated with high-level sulfadoxine-pyrimethamine resistance, prevalences of P. falciparum dihydrofolate reductase 164L (up to 80%) and dihydropteroate synthase 581G (up to 67%) were high at multiple sites. Considering P. falciparum kelch protein propeller domain mutations associated with artemisinin delayed clearance, prevalence of the 469Y and 675V mutations has increased at multiple sites in northern Uganda (up to 23% and 41%, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We demonstrate concerning spread of mutations that may limit efficacies of key antimalarial drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa687","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T16:12:09Z","timestamp":1603815129000},"page":"985-994","source":"Crossref","is-referenced-by-count":202,"title":["Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda"],"prefix":"10.1093","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-4692","authenticated-orcid":false,"given":"Victor","family":"Asua","sequence":"first","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D","family":"Conrad","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Duvalsaint","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Legac","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Duarte","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tumwebaze","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M","family":"Chin","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A","family":"Cooper","sequence":"additional","affiliation":[{"name":"Dominican University of California, San Rafael, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoke","family":"Yeka","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R","family":"Kamya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam L","family":"Nsobya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bailey","sequence":"additional","affiliation":[{"name":"Brown University, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2021032911265848100_CIT0001","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0002","author":"World Health Organization","year":"2019"},{"key":"2021032911265848100_CIT0003","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1517\/14656566.2012.703651","article-title":"Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence","volume":"13","author":"Bardaj\u00ed","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"2021032911265848100_CIT0004","doi-asserted-by":"crossref","first-page":"e10000407","DOI":"10.1371\/journal.pmed.1000407","article-title":"Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"Dicko","year":"2011","journal-title":"PLoS Med"},{"key":"2021032911265848100_CIT0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(16)30378-4","article-title":"Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis","volume":"17","author":"Gutman","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0006","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","article-title":"Transporters involved in resistance to antimalarial drugs","volume":"27","author":"Valderramos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"2021032911265848100_CIT0007","doi-asserted-by":"crossref","first-page":"e01516-17","DOI":"10.1128\/AAC.01516-17","article-title":"Changing antimalarial drug sensitivities in Uganda","volume":"61","author":"Rasmussen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0008","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/596738","article-title":"In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa","volume":"199","author":"Sisowath","year":"2009","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0009","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/AAC.01413-09","article-title":"Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso","volume":"54","author":"Som\u00e9","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2021032911265848100_CIT0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpddr.2015.05.005","article-title":"Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya","volume":"5","author":"Achieng","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2021032911265848100_CIT0012","doi-asserted-by":"crossref","first-page":"e01818-18","DOI":"10.1128\/AAC.01818-18","article-title":"Changing molecular markers of antimalarial drug sensitivity across Uganda","volume":"63","author":"Asua","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0013","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1051\/parasite\/2016069","article-title":"Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso","volume":"23","author":"Som\u00e9","year":"2016","journal-title":"Parasite"},{"key":"2021032911265848100_CIT0014","first-page":"631","article-title":"Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda","volume":"215","author":"Tumwebaze","year":"2017","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol Rev"},{"key":"2021032911265848100_CIT0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","article-title":"Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria","volume":"29","author":"Naidoo","year":"2013","journal-title":"Trends Parasitol"},{"key":"2021032911265848100_CIT0017","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1073\/pnas.0901415106","article-title":"Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment","volume":"106","author":"Harrington","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021032911265848100_CIT0018","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.2009.80.523","article-title":"Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene","volume":"80","author":"Alifrangis","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"2021032911265848100_CIT0019","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/infdis\/jiy223","article-title":"Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes","volume":"218","author":"Aydemir","year":"2018","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis","volume":"17","author":"Amaratunga","year":"2019","journal-title":"BMC Med"},{"key":"2021032911265848100_CIT0021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2021032911265848100_CIT0022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0023","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/infdis\/jiu467","article-title":"Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study","volume":"211","author":"Taylor","year":"2015","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0024","volume-title":"Artemisinin and artemisinin-based combination therapy resistance","author":"World Health Organization","year":"2017"},{"key":"2021032911265848100_CIT0025","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"20","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"2021032911265848100_CIT0026","article-title":"Presence of k13 561H artemisinin resistance mutations in Plasmodium falciparum infection in Rwanda, 2018 [abstract LB 5295]","author":"Uwimana","year":"2019"},{"key":"2021032911265848100_CIT0027","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","article-title":"Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in southeast of Tanzania","volume":"10","author":"Bwire","year":"2020","journal-title":"Sci Rep"},{"key":"2021032911265848100_CIT0028","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4269\/ajtmh.16-0483","article-title":"Artemisinin resistance-associated K13 polymorphisms of Plasmodium falciparum in southern Rwanda, 2010\u20132015","volume":"95","author":"Tacoli","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2021032911265848100_CIT0029","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2021032911265848100_CIT0030","doi-asserted-by":"crossref","first-page":"12345-19","DOI":"10.1128\/AAC.01234-19","article-title":"The diversity of the Plasmodium falciparum K13 propeller domain did not increase after implementation of artemisinin-based combination therapy in Uganda","volume":"63","author":"Conrad","year":"2019;","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0031","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"2021032911265848100_CIT0032","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"Price","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2021032911265848100_CIT0033","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0034","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0035","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat Commun"},{"key":"2021032911265848100_CIT0036","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1365-3156.2006.01742.x","article-title":"Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya","volume":"11","author":"Holmgren","year":"2006","journal-title":"Trop Med Int Health"},{"key":"2021032911265848100_CIT0037","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/AAC.00209-10","article-title":"Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0038","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.05141-14","article-title":"Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from Ugandan children","volume":"59","author":"Tumwebaze","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021032911265848100_CIT0039","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/s41467-020-15779-8","article-title":"The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC","volume":"11","author":"Verity","year":"2020","journal-title":"Nat Commun"},{"key":"2021032911265848100_CIT0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0041","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/375419","article-title":"Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi","volume":"187","author":"Kublin","year":"2003","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0042","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.13-0647","article-title":"Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda","volume":"91","author":"Mbogo","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2021032911265848100_CIT0043","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2875-12-103","article-title":"Temporal trends of molecular markers associated with artemether-lumefantrine tolerance\/resistance in Bagamoyo district, Tanzania","volume":"12","author":"Malmberg","year":"2013","journal-title":"Malar J"},{"key":"2021032911265848100_CIT0044","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/molbev\/msu140","article-title":"Origin of robustness in generating drug-resistant malaria parasites","volume":"31","author":"K\u00fcmpornsin","year":"2014","journal-title":"Mol Biol Evol"},{"key":"2021032911265848100_CIT0045","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","article-title":"Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial","volume":"393","author":"Kajubi","year":"2019","journal-title":"Lancet"},{"key":"2021032911265848100_CIT0046","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3201\/eid1405.071601","article-title":"Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2021032911265848100_CIT0047","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2021032911265848100_CIT0048","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiv551","article-title":"Artesunate\/amodiaquine versus artemether\/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial","volume":"213","author":"Yeka","year":"2016","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0049","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/infdis\/jiy637","article-title":"Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children","volume":"219","author":"Yeka","year":"2019","journal-title":"J Infect Dis"},{"key":"2021032911265848100_CIT0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2019.06.001","article-title":"Elucidating mechanisms of drug-resistant Plasmodium falciparum","volume":"26","author":"Ross","year":"2019","journal-title":"Cell Host Microbe"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa687\/36094199\/jiaa687.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/6\/985\/36785277\/jiaa687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/223\/6\/985\/36785277\/jiaa687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T07:28:36Z","timestamp":1617002916000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/223\/6\/985\/5955967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,4]]},"published-print":{"date-parts":[[2021,3,29]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa687","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,15]]},"published":{"date-parts":[[2020,11,4]]}}}